Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Correlative Study of Melanoma Tumor-Infiltrating Lymphocytes (TILs) and Response to Ipilimumab

NCT01715077 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT01715077
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01715077 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Correlative Study of Melanoma Tumor-Infiltrating Lymphocytes (TILs) and Response to Ipilimumab
Lead sponsor
University Health Network, Toronto
Phase
Not applicable
Overall status
Completed
Start date
October 31, 2012
Completion date
October 31, 2017
Enrollment
4 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

previously untreated and histologically confirmed stage iii (unresectable) or stage iv melanoma